



Markets
/
Stocks
/
nasdaq-dxcm
/

Dexcom Inc

DXCM

View Detailed Chart

71.380USD

+0.079+0.11%

Close 04/30, 16:00（ET）Quotes delayed by 15 min

27.89BMarket Cap

48.40P/E TTM



Dexcom Inc

71.380

+0.079+0.11%

Company

Intraday

30m

Today

+0.11%

5 Days

+6.76%

1 Month

-12.91%

6 Months

+1.28%

Year to Date

-8.22%

1 Year

-43.97%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 27 analysts

BUY

Current Rating

100.605

Target Price

41.10%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

111

Total

Median

Average

Company name

Ratings

Analysts

Dexcom Inc

DXCM

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Insulet Corp

PODD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(3)

Buy(4)

Indicators

Sell(1)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

2.449

Neutral

RSI(14)

48.167

Neutral

STOCH(KDJ)(9,3,3)

81.375

Neutral

ATR(14)

3.181

Low Volatility

CCI(14)

108.024

Buy

Williams %R

15.850

Overbought

TRIX(12,20)

-0.687

Sell

StochRSI(14)

93.655

Overbought

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

70.356

Buy

MA10

69.075

Buy

MA20

66.892

Buy

MA50

79.267

Sell

MA100

78.497

Sell

MA200

80.365

Sell

News

More news coming soon, stay tuned...

Company

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Company codeDXCM

CompanyDexcom Inc

CEOMr. Kevin R. Sayer

Websitehttps://www.dexcom.com/